Researchers from the University of Waterloo have developed a new technology that can hold an entire course of antibiotics in ...

Researchers from the University of Waterloo have developed a new technology that can hold an entire course of antibiotics in ...

Antibiotics have served as the mainstay ... or Clindamycin 300 mg orally twice daily for 7 days Bacterial vaginosis (BV) is a condition characterized by a loss of the indigenous vaginal ...

Researchers have developed a new technology that can hold an entire course of antibiotics in one tiny dose and deliver on demand just the right amount of medication that a particular patient needs to ...

Bacterial vaginosis is confined to an asymptomatic state in at least half of the cases. Symptomatic BV, on the other hand, is most typically accompanied by foul-smelling, profuse vaginal discharge ...

In some experiments, the surviving antibiotic-resistant cells have become enriched, leading to a greater possibility of their adapting to combination treatments.

The prevalence of sexually transmitted infections (STIs) was high among women who reported symptoms of bacterial vaginosis and vaginitis, and highly complex associations were observed between STIs ...

These antibiotics not only combat a wide range of bacteria but also effectively prevent the development of bacterial resistance. By employing atomic engineering, the researchers transformed ...

the findings suggest that microbial therapeutics could be used to tweak the ecology of the gut and suppress harmful bacterial infections with fewer negative side effects than typical antibiotic ...